Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Kerr

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 25, 2010
Histogram based quantification of spinal cord injury level using somatosensory evoked potentialsHasan Mir, Hasan Al-Nashash, Douglas Kerr, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|June 16, 2005
Situational analysis of dietary challenges of the treatment regimen for children and adolescents with phenylketonuria and their primary caregiversCarolyn E Ievers-Landis, Ahna L Hoff, Caitlin Brez, et al.
BMC Neuroscience|March 10, 2011
Proteomic assessment of a cell model of spinal muscular atrophyChia-Yen Wu, Dosh Whye, Lisa Glazewski, et al.
Journal of Mass Spectrometry : JMS|July 12, 2002
Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humansBlandine Comte, Takhar Kasumov, Bradley A Pierce, et al.
Glia|January 20, 2005
Glial restricted precursors protect against chronic glutamate neurotoxicity of motor neurons in vitroNicholas J Maragakis, Mahendra S Rao, Jeronia Llado, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2011
Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenanceDaniel M Harrison, Douglas E Gladstone, Edward Hammond, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2009
Using global statistical tests in long-term Parkinson's disease clinical trialsPeng Huang, Christopher G Goetz, Robert F Woolson, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
Phenylbutyrate increases pyruvate dehydrogenase complex activity in cells harboring a variety of defectsRosa Ferriero, Audrey Boutron, Michele Brivet, et al.
Molecular Genetics and Metabolism|December 12, 2018
Intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A: A phase IIb randomized trialFrits A Wijburg, Chester B Whitley, Joseph Muenzer, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 12, 2014
Commonalities and challenges in the development of clinical trial measures in neurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 25, 2010
Histogram based quantification of spinal cord injury level using somatosensory evoked potentialsHasan Mir, Hasan Al-Nashash, Douglas Kerr, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|June 16, 2005
Situational analysis of dietary challenges of the treatment regimen for children and adolescents with phenylketonuria and their primary caregiversCarolyn E Ievers-Landis, Ahna L Hoff, Caitlin Brez, et al.
BMC Neuroscience|March 10, 2011
Proteomic assessment of a cell model of spinal muscular atrophyChia-Yen Wu, Dosh Whye, Lisa Glazewski, et al.
Journal of Mass Spectrometry : JMS|July 12, 2002
Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humansBlandine Comte, Takhar Kasumov, Bradley A Pierce, et al.
Glia|January 20, 2005
Glial restricted precursors protect against chronic glutamate neurotoxicity of motor neurons in vitroNicholas J Maragakis, Mahendra S Rao, Jeronia Llado, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2011
Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenanceDaniel M Harrison, Douglas E Gladstone, Edward Hammond, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2009
Using global statistical tests in long-term Parkinson's disease clinical trialsPeng Huang, Christopher G Goetz, Robert F Woolson, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
Phenylbutyrate increases pyruvate dehydrogenase complex activity in cells harboring a variety of defectsRosa Ferriero, Audrey Boutron, Michele Brivet, et al.
Molecular Genetics and Metabolism|December 12, 2018
Intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A: A phase IIb randomized trialFrits A Wijburg, Chester B Whitley, Joseph Muenzer, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 12, 2014
Commonalities and challenges in the development of clinical trial measures in neurologyJesse M Cedarbaum, Diane Stephenson, Richard Rudick, et al.
Pageof 3